Methods and tools designed to reduce the risk of incorrect medication are needed more than ever and the demand for quality control systems for compounded medicines is increasing sharply. With proven, efficient and well-functioning solutions, Pharmacolog is ready to meet this increased demand. The company is now at the beginning of a strong expansion and has, after a sharp increase in sales in 2021, begun the journey towards increased profitability and growth. Pharmacolog's CEO, Mats Högberg, will talk more about the company's operations and comment on the recent press releases at Småbolagsdagarna 2022.
On June 13th at 09:00-09:30, Pharmacolog will participate in Aktiespararna's event Småbolagsdagarna 2022. Mats Högberg, CEO, will present Pharmacolog and answer your questions about the company.
The company invites you as a journalist, analyst and shareholder to take part in the presentation live on the web, via http://www.aktiespararna.se/tv/live. The event is open to everyone and does not require membership with Aktiespararna. No registration is required to follow the event digitally.
Take the opportunity to ask your questions to Mats Högberg by sending a text message to 079-347 98 45 or email firstname.lastname@example.org. Your questions will be conveyed by Aktiespararna's moderator in connection with the question and answer session after the presentation. You can submit your questions now or in connection with the presentation.
Pharmacolog provides solutions and products that enhance work efficiency and safety when preparing injectable medication. Our goal is to help prevent medication errors and ensure maximum medication efficacy when treating patients with powerful yet potentially harmful injectable drugs. Pharmacolog’s products, DrugLog®, WasteLog® and PrepLog®, help staff at pharmacies and hospital wards minimize the risk of errors in the compounding process. Furthermore, by verifying that drugs and narcotics used in surgery have not been tampered with, our solutions also make a vital contribution to preventing drug diversion.